CSIM Educational Sessions
Complications of Cancer Immunotherapy
Dr. Lacey Pitre, Northern Ontario School of Medicine, London, ON
April 6, 2022
12:00-1:00pm Eastern Time
Learning Objectives
- Describe the most common settings in which a patient would be offered immunotherapy for cancer.
- Describe the patterns of response to and complications from immunotherapy for cancer.
- Identify criteria used to inform the initiation, maintenance and discontinuation of immunotherapy in cancer patients
- Recognize the perspective and experience of a patient receiving immunotherapy for cancer.
MOC Accreditation
The live online activity: Complications of Cancer Immunotherapy is an educational activity approved as an Accredited Group Learning Activity under Section 1 of the Framework of Continuing Professional Development options as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. As an accredited provider, CSIM has approved this program for 1 credit hour.
Please note:
- View faculty and planning committee conflict of interest disclosures.
- Physicians should only claim credit commensurate with the extent of their participation in the activities.
- Claim your MOC credits at the Royal College of Physicians and Surgeons of Canada Mainport site.
About Dr. Lacey Pitre
Dr. Lacey Pitre is originally from Sudbury, ON and graduated from the Northern Ontario School of Medicine (NOSM) in 2010. She completed her Internal Medicine residency and Medical Oncology fellowship at McMaster University. She is currently in her fifth year of practice at the Northeast Cancer Centre in Sudbury and specializes in breast and lung cancers.
She is the Lead for Cancer Clinical Trials at her centre and is the local principal investigator on several clinical trials in the breast, lung and head & neck field. She is an assistant professor at the Northern Ontario School of Medicine and is the Cancer Care Ontario Lead for Systemic Therapy (Northeastern Ontario region) for Ontario Health/Cancer Care Ontario.